Intravenous Immune Globulin for the Treatment of Presumed Quinidine-Induced Thrombocytopenia
- 1 July 1990
- journal article
- case report
- Published by SAGE Publications in DICP
- Vol. 24 (7-8) , 693-695
- https://doi.org/10.1177/106002809002400706
Abstract
Quinidine is cited as one of the most frequent causes of drug-induced thrombocytopenia. This case report describes the use of high-dose intravenous gamma globulin to rapidly reverse qunidine-induced thrombocytopenia in a patient at increased risk for bleeding because of the presence of an antitachycardia pacemaker and an automatic implantable cardiac defibrillator. This report suggests that this treatment may aid in a more rapid reversal of quinidine-induced thrombocytopenia in patients at high risk of bleeding.Keywords
This publication has 9 references indexed in Scilit:
- Correction of Severe Heparin-Associated Thrombocytopenia with Intravenous ImmunoglobulinAnnals of Internal Medicine, 1989
- Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin [see comments]Blood, 1988
- Immunotherapy of Idiopathic Thrombocytopenic Purpura and Autoimmune NeutropeniaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
- Treatment of gold‐induced thrombocytopenia by high‐dose intravenous gamma globulinArthritis & Rheumatism, 1986
- Drug-Induced Platelet DestructionSeminars in Thrombosis and Hemostasis, 1982
- Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitroBlood, 1981
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- Quinidine-Induced Thrombocytopenia With Pulmonary HemorrhageArchives of internal medicine (1960), 1980